BACE1 and Alzheimer disease: Western blot analysis revealed that cerebral BACE1 levels were ~ 2.1-fold elevated in AD patients compared to non-AD (Fig. 2c), which is in agreement with previous studies where BACE1 protein and activity levels were found to be increased in the brain regions affected by amyloid deposition25–28.